Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Murphy

Showing results (511-520 of 751) with videos related to

Pageof 76
Sort By:
Urology|November 1, 1977
Inhibitory effects of Estracyt on R-3327 rat prostatic carcinomaJ Müntzing, R Y Kirdani, J Saroff, et al.
The Prostate|January 5, 2000
Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint scintiscansG P Murphy, P B Snow, J Brandt, et al.
Journal of Surgical Oncology|December 1, 1982
Intermittent hemodialysis therapy in the cancer patientS Beckley, L Z Wajsman, J E Pontes, et al.
Cryobiology|March 1, 1970
The use of a pulsatile bloodless perfusion system in organ preservationM J Ward, J J van Zyl, J H Groenewald, et al.
The Journal of Urology|May 1, 1983
Immunotherapy of a murine renal cancerR P Huben, R Connelly, M H Goldrosen, et al.
Acta Endocrinologica|May 1, 1981
A model for studies on the response of the ventral prostate to oestrogensJ J Corrales, P A Høisaeter, N Kadohama, et al.
Urology|December 1, 1982
Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National SurveyR Huben, N Natarajan, E Pontes, et al.
The Journal of Urology|August 1, 1980
Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patientsJ P Karr, Z Wajsman, R Y Kirdani, et al.
Cancer|July 1, 1992
Relapsing diseaseG P Murphy, C Mahler, R C Ho, et al.
Biochemistry|July 15, 1975
Synthesis properties of the naturally occurring N-[(9-beta-D-ribofuranosylpurin-6-yl)-N-methylcarbamoyl]-L-threonine (mt-6A) and other related synthetic analogsS P Dutta, C I Hong, G P Murphy, et al.
Pageof 76

Showing results (511-520 of 751) with videos related to

Sort By:
Pageof 76
Urology|November 1, 1977
Inhibitory effects of Estracyt on R-3327 rat prostatic carcinomaJ Müntzing, R Y Kirdani, J Saroff, et al.
The Prostate|January 5, 2000
Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint scintiscansG P Murphy, P B Snow, J Brandt, et al.
Journal of Surgical Oncology|December 1, 1982
Intermittent hemodialysis therapy in the cancer patientS Beckley, L Z Wajsman, J E Pontes, et al.
Cryobiology|March 1, 1970
The use of a pulsatile bloodless perfusion system in organ preservationM J Ward, J J van Zyl, J H Groenewald, et al.
The Journal of Urology|May 1, 1983
Immunotherapy of a murine renal cancerR P Huben, R Connelly, M H Goldrosen, et al.
Acta Endocrinologica|May 1, 1981
A model for studies on the response of the ventral prostate to oestrogensJ J Corrales, P A Høisaeter, N Kadohama, et al.
Urology|December 1, 1982
Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National SurveyR Huben, N Natarajan, E Pontes, et al.
The Journal of Urology|August 1, 1980
Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patientsJ P Karr, Z Wajsman, R Y Kirdani, et al.
Cancer|July 1, 1992
Relapsing diseaseG P Murphy, C Mahler, R C Ho, et al.
Biochemistry|July 15, 1975
Synthesis properties of the naturally occurring N-[(9-beta-D-ribofuranosylpurin-6-yl)-N-methylcarbamoyl]-L-threonine (mt-6A) and other related synthetic analogsS P Dutta, C I Hong, G P Murphy, et al.
Pageof 76